Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Regular physical activity improves cardiovascular health, lowers mortality risk

The majority of citizens in developed countries should not be concerned by potential harm from exercise but rather by the lack of exercise in their lives, according to a clinical perspective published today in the Journal of the American College of Cardiology from the ACC Sports and Exercise Cardiology Leadership Council.

19 Jan 2016

Mount Sinai Heart starts TANSNIP-PESA study to determine how workplace-based lifestyle intervention reduces CV risk

World-renowned cardiologist Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, is undertaking a three-year study, known as the TANSNIP-PESA study, to determine whether a workplace-based lifestyle intervention, accompanied by imaging data, will lead to a reduction in the prevalence of cardiovascular (CV) disease risk factors related to lifestyle.

19 Jan 2016

Eating habits may influence sleep quality

A new study found that eating less fiber, more saturated fat and more sugar is associated with lighter, less restorative, and more disrupted sleep.

18 Jan 2016

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

Novartis announced today that the US Food and Drug Administration has approved Cosentyx (secukinumab) for two new indications - the treatment of adult patients with active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).

17 Jan 2016

New discovery may help researchers tackle mitochondrial diseases and age-related diseases

Buck Institute faculty Judith Campisi, PhD, says age researchers need to stop thinking of cellular senescence, now accepted as an important driver of aging, as a single phenotype that stems from genotoxic stress. Research from her lab reveals that cellular senescence, a process whereby cells permanently lose the ability to divide, is also induced by signaling from dysfunctional mitochondria - and that the arrested cells secrete a distinctly different "stew" of biologically active factors in a process unrelated to the damaging free radicals that are created in mitochondria as part of oxygen metabolism.

13 Jan 2016

CPMC study discovers six genes that affect sleep duration

The Coriell Personalized Medicine Collaborative, a research initiative exploring the utility of genetic information in the clinical setting, has published a study and identified six noteworthy genes that affect human sleep duration.

13 Jan 2016

IMB scientists identify two proteins vital for demethylation of DNA

Scientists at the Institute of Molecular Biology in Mainz have identified a missing piece of the puzzle in understanding how epigenetic marks are removed from DNA. The research on DNA demethylation sheds new light on a fundamental process that is important in development and diseases such as cancer.

12 Jan 2016

Study opens new door on the causes of vision issues in astronauts

Just when you think you've seen it all, our eyes look to be victims of a low-gravity environments, too. According to new research published in the January 2016 issue of The FASEB Journal, two significant genetic differences in enzymes that direct the one-carbon pathway of metabolism can affect astronaut vision.

12 Jan 2016

Genetic factors in puberty timing: an interview with Dr John Perry

The study focused on the genetic regions that influence age at voice breaking - a distinct developmental milestone that happens to young men as their larynx (voice box) lengthens when exposed to male hormones.

11 Jan 2016

AngioDefender holds much promise for personalized cardiac care

For a non-descript box it wields a mighty name and even more impressive possibilities for people with heart disease. Called the AngioDefender, the machine - no bigger than a shoebox - holds much promise in the ability to personalize cardiac care, say researchers at Lawson Health Research Institute, the research arm of St. Joseph's Health Care London.

8 Jan 2016

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients.

7 Jan 2016

Scientists successfully create fully-functional pancreatic cells from human skin cells

Scientists at the Gladstone Institutes and the University of California, San Francisco have successfully converted human skin cells into fully-functional pancreatic cells. The new cells produced insulin in response to changes in glucose levels, and, when transplanted into mice, the cells protected the animals from developing diabetes in a mouse model of the disease.

6 Jan 2016

Global action on reducing mercury emissions should lead to billions in economic benefits for U.S.

Mercury pollution is a global problem with local consequences: Emissions from coal-fired power plants and other sources travel around the world through the atmosphere, eventually settling in oceans and waterways, where the pollutant gradually accumulates in fish. Consumption of mercury-contaminated seafood leads to increased risk for cardiovascular disease and cognitive impairments.

6 Jan 2016

Study reveals promising mechanism for attacking Ebola virus

In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.

5 Jan 2016

Obesity studies underestimate effects of excess weight on mortality

Researchers from the Boston University School of Public Health and the University of Pennsylvania have found that prior studies of the link between obesity and mortality are flawed because they rely on one-time measures of body mass index (BMI) that obscure the health impacts of weight change over time.

5 Jan 2016

Heart attack patients with bypass history more likely to have delayed treatment

Heart attack patients who had previously undergone cardiac bypass surgery are about twice as likely to have a delay in receiving angioplasty, or another form of revascularization, compared to heart attack patients who had no history of bypass surgery or previous angioplasty.

31 Dec 2015

Healthier weight using genetic data for customized diets and physical activity plans

Some health experts predict that the next big advance in helping overweight people achieve a healthier weight will be to use an individual's genetic data to customize diets and physical activity plans, an approach known as "precision weight loss.

24 Dec 2015

TEDA International Cardiovascular Hospital passes JCI and HIMSS Stage 7 assessment

On December 12, 2015, TEDA International Cardiovascular Hospital (TEDA) was validated by HIMSS Analytics with the Stage 7 Award, making it the first hospital in China which has passed JCI and HIMSS Stage 7 assessment at the same time.

24 Dec 2015

Novel antibody improves glucose regulation and reduces fatty liver in obese mice

A new study by researchers from Harvard T.H. Chan School of Public Health and colleagues describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.

24 Dec 2015

NEJM publishes results of Cosentyx Phase III studies in ankylosing spondylitis

Novartis announced today that the results of the MEASURE 1 and MEASURE 2 Phase III studies for Cosentyx® (secukinumab) in ankylosing spondylitis (AS) were published in The New England Journal of Medicine (NEJM). These pivotal studies demonstrated significant clinical improvements with Cosentyx versus placebo in reducing the signs and symptoms of active AS – a long-term, painful and debilitating inflammation of the spine.

24 Dec 2015

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Regular physical activity improves cardiovascular health, lowers mortality risk

Mount Sinai Heart starts TANSNIP-PESA study to determine how workplace-based lifestyle intervention reduces CV risk

Eating habits may influence sleep quality

Novartis announces FDA approval of Cosentyx for treatment of adult patients with AS and PsA

New discovery may help researchers tackle mitochondrial diseases and age-related diseases

CPMC study discovers six genes that affect sleep duration

IMB scientists identify two proteins vital for demethylation of DNA

Study opens new door on the causes of vision issues in astronauts

Genetic factors in puberty timing: an interview with Dr John Perry

AngioDefender holds much promise for personalized cardiac care

FDA-approved, once-daily 24-hour aspirin now available for prevention of stroke and acute cardiac events

Scientists successfully create fully-functional pancreatic cells from human skin cells

Global action on reducing mercury emissions should lead to billions in economic benefits for U.S.

Study reveals promising mechanism for attacking Ebola virus

Obesity studies underestimate effects of excess weight on mortality

Heart attack patients with bypass history more likely to have delayed treatment

Healthier weight using genetic data for customized diets and physical activity plans

TEDA International Cardiovascular Hospital passes JCI and HIMSS Stage 7 assessment

Novel antibody improves glucose regulation and reduces fatty liver in obese mice

NEJM publishes results of Cosentyx Phase III studies in ankylosing spondylitis

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in